0
Breast Cancer: Is the ER (estrogen receptor) something genetic or is it variable based on medication (ie. chemotherapy)?
- 1 people answered
1 Vote
1 Contributor
1630 Views 
0 Saved
1 Vote 1 Contributor1630 Views 0 SavedYou might also be interested in
A number of masses can be found within the female breast but not all of them are cancerous. So, don’t panic if you find a mass. Among the benign masses, most are only an inconvenience and have no threat, but some may be associated with increased long-term risk of breast cancer. A fibroadenoma is a ....
It’s very much unlikely. If the opposite armpit develops swollen nodes, it could be anything from an ingrown hair to a skin disease, to a swollen lymph node caused by an infection or even an injury down your arm. Many of these conditions require further testing or treatment. It is important to see y....
Vulvar Paget's disease is a type of skin cancer of the Vulva. It presents as redness, velvety appearance with white islands of tissue. This is accompanied by itching and pain. If you have any such symptoms, contact your oncologist/gynaecologist for further treatment.
Mahima Chaudhary
Receptors are proteins in or on cells that can attach to certain substances in the blood. Normal breast cells and some breast cancer cells have receptors that attach to the hormones estrogen and progesterone, and depend on these hormones to grow.
The breast tissue estrogen receptor is both genetic and variable in the presence of chemotherapy and other medications.
Breast cancer cells may have one, both, or none of these receptors.
ER-positive: Breast cancers that have estrogen receptors are called ER-positive (or ER+) cancers.
PR-positive: Breast cancers with progesterone receptors are called PR-positive (or PR+) cancers.
Keeping these receptors from attaching to the hormones can help keep the cancer from growing and spreading. There are drugs that can be used to do this.
Knowing the hormone receptor status of your cancer helps doctors decide how to treat it. If your cancer has one or both of these hormone receptors, hormone therapy drugs can be used to either lower estrogen levels or stop estrogen from acting on breast cancer cells. This kind of treatment is helpful for hormone receptor-positive breast cancers, but it doesn’t work on tumors that are hormone receptor-negative (both ER- and PR-negative).